Anavex Life Sciences
AVXL
AVXL
49 hedge funds and large institutions have $10.5M invested in Anavex Life Sciences in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3.66% less ownership
Funds ownership: 18.08% → 14.42% (-3.7%)
53% less capital invested
Capital invested by funds: $22.3M → $10.5M (-$11.8M)
88% less call options, than puts
Call options by funds: $75K | Put options by funds: $646K
Holders
49
Holding in Top 10
1
Calls
$75K
Puts
$646K
Top Buyers
| 1 | +$231K | |
| 2 | +$83.4K | |
| 3 | +$49K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$43.9K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$37.7K |
Top Sellers
| 1 | -$1.59M | |
| 2 | -$730K | |
| 3 | -$317K | |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$191K |
| 5 |
ECM
Element Capital Management
New York
|
-$183K |